The CSF level of NSE has also been studied in neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy body disease (LBD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Here, ENO2 is linked to multiple system atrophy.